Teriparatide

Type: Keyphrase
Name: Teriparatide
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Amgen announces encouraging results from Phase III fracture analysis

From January to March 2012, this study examined 6,187 women at or over age 50 at high risk for fracture in the MarketScan Commercial and Medicare databases who newly initiated treatment with Prolia or other osteoporosis therapies (teriparatide, raloxifene, ... [Published Individual.com - 23 hours ago]
First reported Sep 15 2014 - Updated Sep 16 2014 - 1 reports

Advisory Committee recommends approval of PTH therapy for hypoparathyroidism

After a debate-filled meeting today, the Endocrinologic and Metabolic Drugs Advisory Committee voted 8 to 5 in favor of approval for recombinant human parathyroid hormone, rhPTH I-84, to be known as Natpara, for long-term management of hypoparathyroi ... [Published Orthopedics Today - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 2 reports

Amgen: Phase 2 Study Of Romosozumab Shows Increases In Bone Mineral Density

Amgen (AMGN: Quote) and UCB on Monday announced positive results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density ("BMD"). Romosozumab is an investigational bone-forming ... [Published RTTNews.com - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Genetics of Osteogenesis Imperfecta and Phenotypic Implications

Osteogenesis imperfecta (OI), a skeletal disorder caused by mutations in type I collagen, exhibits structural and functional differences on a genotypic level that contribute to diverse phenotypes.Brendan Lee, MD, PhD, from the Baylor College of Medicine ... [Published American Journal of Managed Care - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 13 2014 - 2 reports

How do osteoporosis drugs compare? Who knows!

A systematic review of various medications to treat osteoporosis was not able to conclude much about the comparative effectiveness of the drugs.A team of researchers, led by Carolyn J. Crandall, MD, from the University of California, Los Angeles, reviewed ... [Published Pharmacist.com - Sep 13 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Healthcare Watch September 2014

Discoveries/Innovations: Nanotech Microchip Detects and Monitors Type 1 DiabetesResearchers at Stanford University have invented a portable microchip-based test for diagnosing type 1 diabetes that can potentially improve patient care and help researchers ... [Published PM 360 - Sep 12 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 1 reports

Osteoporosis Drugs Work, But Review Finds No Clear Winner

By Amy NortonHealthDay ReporterMONDAY, Sept. 8, 2014 (HealthDay News) -- Many osteoporosis drugs cut women's risk of suffering a bone fracture, though it's not clear whether any one medication works better than others, a new research review finds.Reporting ... [Published US News & World Report - Sep 08 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 1 reports

Tip sheet from Annals of Internal Medicine, Sept. 9, 2014

PUBLIC RELEASE DATE: 8-Sep-20141. Health insurance not affordable for many under Affordable Care ActFor many younger adults, the penalty for not buying health insurance may be less than the price of the least expensive plan available under the Patient ... [Published EurekAlert! - Sep 08 2014]
First reported Aug 30 2014 - Updated Aug 30 2014 - 1 reports

MKSAP: 55-year-old man with a wrist fracture and anemia

Test your medicine knowledge with the  MKSAP challenge , in partnership with the  American College of Physicians . A 55-year-old man is reevaluated during a follow-up examination for a wrist fracture and anemia. The patient is otherwise asymptomatic. ... [Published KevinMD.com - Aug 30 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Potential Role of Network Meta-Analysis in Value-Based Insurance Design

James D. Chambers, PhD, MPharm, MSc; Aaron Winn, MPP; Yue Zhong, MD, PhD; Natalia Olchanski, MS; and Michael J. Cangelosi, MA, MPHIt is estimated that more than 10 million Americans 50 years or older have osteoporosis and more than 43 million have low ... [Published American Journal of Managed Care - Aug 26 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Radius Health Announces Presentations at the American Society for Bone and Mineral Research 2014 Annual Meeting

Meeting to Include New Responder Analysis of Effects of Abaloparatide on Bone Mineral Density in Postmenopausal Women With OsteoporosisCAMBRIDGE, Mass., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that it will present ... [Published Virtual Strategy Magazine - Aug 19 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Human medicines European public assessment report (EPAR): Forsteo, teriparatide, Revision: 15, Authorised

Quotes

This absence of data led Dr. Bischoff-Ferrari and Dr. Meyer to write that, "Although this is helpful information to guide clinicians and their patients, we believe that they should recognize that these conclusions may not apply to patients aged 75 years or older, and especially not to those aged 80 years or older with nonskeletal risk factors for falls. Such patients are insufficiently represented in the clinical trials of pharmacologic treatments for fracture prevention included in this careful evidence review."
"After going through such extremes to stay alive, I consider my every day here a small miracle," she says. "It was not my time to leave this world yet, and I plan on making the best of every day I've been given."
"The benefits for most people with osteoporosis far outweigh the risks," said Recker, who wasn't involved in the study. "There's broad consensus that they lower the risk of fracture."

More Content

All (22) | News (18) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Amgen announces encouraging results from Phase ... [Published Individual.com - 23 hours ago]
Amgen: Phase 2 Study Of Romosozumab Shows Incre... [Published RTTNews.com - Sep 15 2014]
New Analyses Of Phase 2 Study Presented At ASBM... [Published Bio-Medicine - Sep 15 2014]
Genetics of Osteogenesis Imperfecta and Phenoty... [Published American Journal of Managed Care - Sep 15 2014]
Advisory Committee recommends approval of PTH t... [Published Orthopedics Today - Sep 15 2014]
How do osteoporosis drugs compare? Who knows! [Published Pharmacist.com - Sep 13 2014]
Healthcare Watch September 2014 [Published PM 360 - Sep 12 2014]
Osteoporosis Drugs Lower Fracture Risk, but Bes... [Published Medscape Women's Health - Sep 12 2014]
I Almost Died From a Mineral Deficiency [Published Cosmopolitan - Sep 08 2014]
Osteoporosis Drugs Work, But Review Finds No Cl... [Published US News & World Report - Sep 08 2014]
Tip sheet from Annals of Internal Medicine, Sep... [Published EurekAlert! - Sep 08 2014]
More Evidence Ties Some Bone-Building Drugs to ... [Published Health Finder - Sep 04 2014]
MKSAP: 55-year-old man with a wrist fracture an... [Published KevinMD.com - Aug 30 2014]
Potential Role of Network Meta-Analysis in Valu... [Published American Journal of Managed Care - Aug 26 2014]
Radius Health Announces Presentations at the Am... [Published Virtual Strategy Magazine - Aug 19 2014]
Radius Health Announces Presentations at the Am... [Published EMoneyDaily - Aug 19 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 23 2014]
Critical Pharmaceuticals receives notice of all... [Published PBR - News - Apr 09 2014]
On the Move [Published Argus Leader - Mar 24 2014]
Sanford announces seed grant research funding w... [Published Argus Leader - Mar 21 2014]
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Combination treatment with strontium for the pr... [Published PharmCast - Jan 22 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
MKSAP: 55-year-old man with a wrist fracture an... [Published KevinMD.com - Aug 30 2014]
Test your medicine knowledge with the  MKSAP challenge , in partnership with the  American College of Physicians . A 55-year-old man is reevaluated during a follow-up examination for a wrist fracture and anemia. The patient is otherwise asymptomatic. ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 23 2014]
Critical Pharmaceuticals receives notice of all... [Published PBR - News - Apr 09 2014]
Critical Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application directed towards the company's CP024 intranasal growth hormone and CP046 intranasal teriparatide (parathyroid ...
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.